It is unknown whether the established risk factors for malignant melanoma in whites influence malignant melanoma risk in non-whites. We examined the risk factors for melanoma among 39,325 whites and 101,229 non-whites/multiracials [Japanese American (47.5%), Latino American (34.8%), Native Hawaiian (2.1%), and multiracial (15.6%), excluding African Americans] in the Multiethnic Cohort study. With an average follow-up of 12.7 years, 581 invasive malignant melanoma (IMM) and 412 melanoma in situ (MIS) cases were identified, of which 107 IMM and 74 MIS were among non-whites/multiracials. The relative risks (RR) and 95% confidence intervals (CI) were estimated by Cox proportional hazards models using days from cohort entry as the underlying time variable. Among non-white/multiracial males, location of IMM tumors differed from those of white males (P < 0.001); and non-white/multiracial females were more likely to be diagnosed with later stage of disease (P < 0.001). After adjusting for potential confounders, age at cohort entry, male sex, higher education, and sunburn susceptibility phenotypes were associated with an increased risk of IMM in non-whites/multiracials (P < 0.05). The risk estimates for age at cohort entry and lighter hair and eye color were greater in non-whites/multiracials than in whites (Pheterogeneity = 0.062, 0.016, and 0.005, respectively). For MIS risk, RRs between whites and non-whites/multiracials also differed for study location and education (Pheterogeneity ≤ 0.015). In conclusion, similar to whites, age at cohort entry, male sex, and susceptibility to sunburn phenotypes may be predictive of malignant melanoma risk in non-white populations excluding African Americans. Cancer Prev Res; 5(3); 423–34. ©2012 AACR.

Melanoma is one of the few cancers with increasing incidence worldwide (1, 2). Although the incidence and its increase are predominantly found among non-Hispanic whites (3), populations commonly known for having lower incidence of disease, such as Japanese in Japan (4, 5), Puerto Ricans (6), Hispanics in California (7) and Florida (8), and the non-whites in New Zealand (9), have also shown an increase in rates. The exact reasons for this are unknown. This increase has been hypothesized to be a result of the growing accessibility to recreational sun exposure (10, 11) and UV radiation (UVR) from tanning beds (12, 13); as well as increasing cancer surveillance and/or reporting (1). Most epidemiologic studies of malignant melanoma have been conducted in whites and they have identified these risk factors: exposure to UVR from the sun or artificial sources, older age, sunburns, and phenotypes that increase the risk of sunburns (e.g., fair skin color; refs. 14, 15).

The incidence of malignant melanoma among non-whites is relatively low in the United States. The respective age-adjusted incidence rates (per 100,000) for men and women are 4.8 and 4.8 in Hispanics and 1.6 and 1.3 in Asian/Pacific Islanders, compared with 35.8 and 23.3 in non-Hispanic whites (16). Epidemiologic studies of malignant melanoma in non-European or African descendents are scarce; thus, risk factors in non-whites have not been well characterized. This population is often diagnosed at an advanced stage of disease compared with their white counterparts (8, 17–19). Therefore, knowing risk factors in non-whites is necessary for melanoma prevention and the reduction of melanoma-related deaths.

We are unaware of any published cohort studies investigating risk factors for malignant melanoma in non-white or multiethnic populations. Using the Multiethnic Cohort (MEC) study data, we examined whether tumor characteristics and known risk factors for malignant melanoma vary between white and non-white/multiracial (Japanese American, Latino American, Native Hawaiian, and multiracial, excluding African American) populations.

Study population

The MEC is a prospective cohort study established to investigate the association of lifestyle and dietary factors with chronic diseases in a multiethnic population. Details of the study design have been previously published (20). The cohort is composed of 215,251 men and women between the ages of 45 to 75 years at recruitment, primarily belonging to one of these racial/ethnic groups: African Americans, Japanese Americans, Latinos, Native Hawaiians, and whites. Potential participants were identified in Hawaii and California (primarily Los Angeles County) through drivers' license files, voter registration lists, and Health Care Financing Administration files. Between 1993 and 1996, each participant completed a mailed, self-administered questionnaire about demographic, dietary, lifestyle, and other exposure factors. The Institutional Review Boards of the University of Hawaii (Honolulu, HI), the University of Southern California (Los Angeles, CA), and the University of California (Los Angeles, CA) approved this study.

Inclusion and exclusion criteria

In preliminary analyses among non-whites, we found that heterogeneity of risk estimates were greater for some risk factors, such as ever-sunburned status, when including African Americans compared with when excluding African Americans (P = 0.05 vs. 0.15). Therefore, to reduce heterogeneity and possible residual confounding within the non-white/multiracial group, African Americans and part–African Americans (n = 28,119, with just 7 melanoma cases) were excluded. We also excluded participants who (i) did not belong to 1 of the 5 main racial/ethnic groups (n = 13,488), (ii) had an implausible dietary history (n = 8,263), (iii) had a prior history of melanoma or were missing non-melanoma skin cancer (NMSC) history (n = 2,318), (iv) had a prior history of cancer (other than NMSC) before the date of the baseline questionnaire (n = 14,632), or (v) had missing data on variables of interest: education, natural hair and eye color, ever-sunburned status, tanning ability, and skin's reactivity to acute sunlight (n = 7,877).

After all exclusions, the eligible population for invasive malignant melanoma (IMM) included 67,521 men and 73,033 women. Although some melanoma in situ (MIS), if left untreated, may evolve into IMM, the risk of developing into an invasive form is unknown. For instance, in lentigo maligna, a type of MIS, the risk of progression has been reported to be as low as 5% and as high as 50% (21). Therefore, to examine the outcome of MIS, an additional 21 males and 26 females who had a previous history of MIS were also excluded from the at-risk eligible population. We conducted a sensitivity analysis where we used a common at-risk population including participants without a history of IMM or MIS and found that the associations did not differ. Here, malignant melanoma (MM) refers to both IMM and MIS. Excluded participants were slightly older (3.4 years) than those who remained in the analysis. A sensitivity analysis was conducted including those with prior non-melanoma cancers; findings were similar.

Follow-up and case identification

Participants' follow-up began at the completion of the baseline questionnaire and continued until reaching one of these endpoints: (i) diagnosis of IMM, (ii) death, (iii) end of follow-up, December 31, 2007, and, in the instances where MIS was the outcome of interest, (iv) diagnosis of MIS. All incident cases of malignant melanoma were identified by record linkage to the Hawaii Tumor Registry (HTR), the Cancer Surveillance Program (CSP) for Los Angeles County, and the California Cancer Registry (CCR). The HTR and CCRs participate in the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) program, estimated to have more than 99% data completeness (22). Record linkages to the Hawaii and California registries are conducted at least annually. The HTR and the CCR cover their respective state populations, whereas the CSP covers the Los Angeles County area. Linkage was conducted by the tumor registries using personal identifiers of name, birthdate, sex, race and social security number. Partial matches were manually checked to identify further cases. Cases of malignant melanoma were defined by International Classification of Diseases for Oncology (ICD-O-3) histology codes 8720-8790 and site code C44.

We used annual linkages to state death certificate files in California and Hawaii and periodical linkages to the National Death Index to identify deaths within the cohort. Cohort participants were followed for an average of 12.7 years, contributing to a total of 1,780,408 person-years. At the end of follow-up, 581 IMM cases and 412 MIS cases were identified among this eligible population of whites and non-whites/multiracials.

Data

Each participant self-reported one or multiple racial/ethnic categories for themselves and for each parent. This study was restricted to those who selected for themselves at least one of the following: non-Hispanic white, Latino American, Japanese American, or Native Hawaiian. Here, race/ethnicity was defined by self-report of a single racial/ethnicity (e.g., single-race whites will be referred to as “whites”). Participants with more than 1 of the 4 above mentioned racial/ethnic groups were classified as multiracial, of which, the majority categorized themselves as having European American (70.7%) and/or Native Hawaiian ancestry (65.3%). To account for white admixture in multiracials, which presumably would affect risk for melanoma, we also created a part-white status variable (yes and no). Because of the small number of malignant melanoma cases identified in Japanese American, Latino American, Native Hawaiian, and multiracial populations, these groups were combined and labeled as “non-whites/multiracials” (non-whites or multiracials).

Baseline characteristics from the questionnaire were previously published (20). Participants answered questions about their natural hair color at the age of 20 (black, medium or dark brown, light brown, blonde, or red) and eye color (brown or black, blue, gray, and green). More than 99.5% of participants provided a single response. Among those with more than one response, traits were classified according to the greatest pigmented phenotype (i.e., “darkest”). Participants were asked about their skin's tanning ability after repeated sun exposure and unprotected skin's reactivity to 1 hour of acute sun exposure. Ever-sunburned status was defined as ever having a blistering sunburn. The age at which this first occurred and total lifetime number of sunburns were also reported.

Because of the high correlations among sunburn susceptibility phenotypes: hair color, eye color, tanning ability (deeply, moderately, lightly, not at all), and skin's reactivity to acute sunlight (no effect or tans, mild sunburn then tans, severe sunburn, severe sunburn with blistering), we created a sunburn susceptibility phenotype index that categorized the summation of the 4 above mentioned propensity to sunburn phenotypes. The categories of hair color, tanning ability, and skin's reactivity to acute sunlight each had 4 levels (0–3), scaled from lowest to highest risk. We did not detect a gradient of risk within blue, gray, and green eye colors; therefore, the measure of eye color was given 2 levels: dark, 0; light, 1. The sum of all 4 phenotypes assumes equal weight of each of the 4 phenotypic factors on an additive scale (0–10), where 0 is having dark hair, dark eyes, deep tans, and has no reaction or tans in reaction to sunlight and 10 is having red hair, light eyes, does not tan at all, and has blistering sunburn reaction to sunlight. Subsequently, this summed value was categorized into a 5-category sunburn susceptibility phenotype index (0–1, “lowest risk”; 2–3, “low risk”; 4–5, “medium risk”; 6–7, “high risk”; and >7, “highest risk”).

Statistical analyses

Tests for difference in the distribution of stage, histology, and tumor location between whites and non-whites/multiracials were conducted using the χ2 test and Fisher exact test when expected values for one of the cells was less than 5.

Because of differing etiologic factors, acral lentiginous melanoma (ALM) cases were excluded from calculations of relative risks (RR). The other more common histologic subtypes remained in the analysis, as about 58% of cases had not otherwise specified histologies. RRs and 95% confidence intervals (CI) were calculated using Cox proportional hazards models and stratified by race: whites and non-whites/multiracials (Japanese Americans, Latino American, Native Hawaiians, and multiracials). The underlying time variable was days of follow-up, date of cohort entry to date of exit at one of the previously mentioned endpoints. For the IMM analysis, incident MIS cases were followed until death or end of follow-up. For the MIS analysis, incident IMM cases were censored at diagnosis of IMM. All variables of interest met the proportional hazard assumption.

In the minimally adjusted model, we adjusted for age at cohort entry, sex, race/ethnicity, part-white status, study site, and education. For associations between sunburn susceptibility phenotypes and MM, the full regression model included the covariates from the minimally adjusted model with further adjustment for ever-sunburned status, family history of melanoma, and personal history of NMSC. For associations between all other risk factors of interest and MM, a sunburn susceptibility phenotype index (5 levels, explained above) was also included in the full regression model. The results were consistent whether adjusting for all 4 sunburn susceptible phenotypes (hair and eye color, ability to tan, or reactivity to acute sun exposure), 1 of the 4 phenotypes, or the sunburn susceptibility phenotype index. To maximize precision, the index score was used in place of all or one of these phenotypic measures.

Tests for heterogeneity by racial/ethnic groups were evaluated using the likelihood ratio test, which compared the full regression model including the interaction term, product of the race/ethnicity and variable of interest, and a main effects model. Interaction terms were created using the categories described above. The test of heterogeneity between MIS and IMM was conducted using competing risk techniques, where each outcome was a different event. A Wald test was used to compare the parameters between outcomes. All statistical analyses were conducted in SAS version 9.2 (SAS Institute).

Whites were more likely than non-whites/multiracials to have college attendance, phenotypes that increase susceptibility to sunburn (sunburn susceptibility phenotype index >7), blistering sunburns after acute sun exposure, ever-sunburn, a family history of melanoma, and a personal history of NMSC (Table 1). Japanese Americans had the greatest homogeneity in hair and eye color (Supplementary Table S1).

Table 1.

Percent distribution of baseline characteristics, constitutional factors, and sunburn history among eligible participants of the MEC study, 1993–1996

CharacteristicsWhitesNon-whites/multiracialsaP
Totals (N39,325 101,229  
Study site 
 California 29.0% 47.3% <0.001a 
 Hawaii 71.0% 52.7%  
Sex 
 Male 47.3% 48.3% <0.001a 
 Female 52.7% 51.7%  
Race 
 Japanese American  47.5%  
 Latino American  34.8%  
 Native Hawaiian  2.1%  
 Whites 100.0%   
 Multiracials  15.6%  
 Multiracial part-white  70.7%  
 Multiracial not part-white  29.3%  
Education 
 ≤High school 25.9% 51.7% <0.001a 
 Some college 31.2% 26.8%  
 ≥College 42.9% 21.6%  
Age at baseline, y 
 Mean (SD) 58 (9.0) 60 (8.6) <0.001b 
Hair color 
 Black/medium dark brown 57.0% 93.2% <0.001a 
 Light brown 26.2% 6.1%  
 Blonde 13.6% 0.5%  
 Red 3.1% 0.2%  
Eye color 
 Dark (black/dark brown) 40.7% 95.6% <0.001a 
 Light (blue, gray, and green) 59.3% 4.4%  
Tanning ability 
 Deeply 23.5% 30.5% <0.001a 
 Moderately 56.6% 53.2%  
 Lightly 17.5% 14.1%  
 Not at all 2.3% 2.2%  
Skin's reactivity to sunlight 
 No effect or tans 20.0% 45.0% <0.001a 
 Mild sunburn, then tans 49.5% 41.0%  
 Severe sunburn without blistering 19.8% 10.1%  
 Severe sunburn with blistering 10.7% 3.9%  
Sunburn susceptibility phenotype index 
 0–1 15.8% 45.5% <0.001a 
 2–3 40.6% 47.9%  
 4–5 29.0% 5.9%  
 6–7 11.4% 0.7%  
 >7 3.1% 0.1%  
Ever-sunburned 
 No 38.2% 77.4% <0.001a 
 Yes 61.8% 22.6%  
Lifetime number of sunburns 
 No sunburn 38.2% 77.4% <0.001a 
 ≤3 sunburns 40.5% 15.9%  
 >3 sunburns 20.7% 6.2%  
 Missing 0.6% 0.5%  
First age of sunburn 
 Never sunburned 38.2% 77.4% <0.001a 
 <13 y 13.3% 3.1%  
 13–17 y 16.8% 5.0%  
 ≥18 y 31.1% 14.1%  
 Missing 0.7% 0.4%  
Family history of melanoma 
 No 98.8% 99.8% <0.001a 
 Yes 1.2% 0.2%  
History of non-melanoma skin cancer 
 No 88.5% 99.0% <0.001a 
 Yes 11.5% 1.0%  
CharacteristicsWhitesNon-whites/multiracialsaP
Totals (N39,325 101,229  
Study site 
 California 29.0% 47.3% <0.001a 
 Hawaii 71.0% 52.7%  
Sex 
 Male 47.3% 48.3% <0.001a 
 Female 52.7% 51.7%  
Race 
 Japanese American  47.5%  
 Latino American  34.8%  
 Native Hawaiian  2.1%  
 Whites 100.0%   
 Multiracials  15.6%  
 Multiracial part-white  70.7%  
 Multiracial not part-white  29.3%  
Education 
 ≤High school 25.9% 51.7% <0.001a 
 Some college 31.2% 26.8%  
 ≥College 42.9% 21.6%  
Age at baseline, y 
 Mean (SD) 58 (9.0) 60 (8.6) <0.001b 
Hair color 
 Black/medium dark brown 57.0% 93.2% <0.001a 
 Light brown 26.2% 6.1%  
 Blonde 13.6% 0.5%  
 Red 3.1% 0.2%  
Eye color 
 Dark (black/dark brown) 40.7% 95.6% <0.001a 
 Light (blue, gray, and green) 59.3% 4.4%  
Tanning ability 
 Deeply 23.5% 30.5% <0.001a 
 Moderately 56.6% 53.2%  
 Lightly 17.5% 14.1%  
 Not at all 2.3% 2.2%  
Skin's reactivity to sunlight 
 No effect or tans 20.0% 45.0% <0.001a 
 Mild sunburn, then tans 49.5% 41.0%  
 Severe sunburn without blistering 19.8% 10.1%  
 Severe sunburn with blistering 10.7% 3.9%  
Sunburn susceptibility phenotype index 
 0–1 15.8% 45.5% <0.001a 
 2–3 40.6% 47.9%  
 4–5 29.0% 5.9%  
 6–7 11.4% 0.7%  
 >7 3.1% 0.1%  
Ever-sunburned 
 No 38.2% 77.4% <0.001a 
 Yes 61.8% 22.6%  
Lifetime number of sunburns 
 No sunburn 38.2% 77.4% <0.001a 
 ≤3 sunburns 40.5% 15.9%  
 >3 sunburns 20.7% 6.2%  
 Missing 0.6% 0.5%  
First age of sunburn 
 Never sunburned 38.2% 77.4% <0.001a 
 <13 y 13.3% 3.1%  
 13–17 y 16.8% 5.0%  
 ≥18 y 31.1% 14.1%  
 Missing 0.7% 0.4%  
Family history of melanoma 
 No 98.8% 99.8% <0.001a 
 Yes 1.2% 0.2%  
History of non-melanoma skin cancer 
 No 88.5% 99.0% <0.001a 
 Yes 11.5% 1.0%  

aP values calculated using the χ2 test.

bP values calculated using one-way ANOVA.

The tumor characteristics for IMM and MIS among MEC participants stratified by sex and race/ethnicity are presented in Table 2. Approximately, 42% of cases had specific tumor histology information. Non-white/multiracial females were more likely to be diagnosed with later stage disease (P < 0.001). This difference was not found in males. The anatomic location of IMM lesions differed between white and non-white/multiracial males; white males were more likely to have lesions located on the trunk (44.8% vs. 25.8%) and non-white/multiracial males were more likely to have such lesions on the lower limbs, including hips (19.7% vs. 6.3%). In women, the anatomic locations of IMM did not differ by race. However, non-white/multiracial women were more likely to present with MIS on the face (41.2% vs. 21.7%).

Table 2.

IMM and MIS tumor characteristics among participants recruited to the MEC study, 1993–1996, stratified by sex

MalesFemales
WhitesNon-whites/multiracialsWhitesNon-whites/multiracials
IMM 
No. eligible 18,612 48,909 20,713 52,320 
 Total person-years 231,927.6 606,194.1 266,832.2 675,453.8 
 No. of cases 288 66 186 41 
Race 
 Japanese American  12 (18.2)  16 (39.0) 
 Latino American  30 (45.5)  10 (24.4) 
 Multiracials  20 (30.3)  15 (36.6) 
 Native Hawaiian  4 (6.1)  0 (0.0) 
 Whites 288 (100) 0 (0.0) 186 (100) 0 (0.0) 
Histology 
 Melanoma, NOS 179 (62.2) 33 (50.0) 96 (51.6) 17 (41.5) 
 Nodular melanoma 18 (6.3) 5 (7.6) 9 (4.8) 5 (12.2) 
 Lentigo maligna melanoma 23 (8.0) 10 (15.2) 11 (5.9) 2 (4.9) 
 Superficial spreading melanoma 57 (19.8) 9 (13.6) 61 (32.8) 9 (22.0) 
 Acral lentiginous melanoma 2 (0.7) 4 (6.1) 0 (0.0) 6 (14.6) 
 Other 9 (3.1) 5 (7.6) 9 (4.8) 2 (4.9) 
Pa 0.015 <0.001 
Stage 
 Localized 259 (89.9) 57 (86.4) 166 (89.3) 26 (63.4) 
 Regional 15 (5.2) 3 (4.6) 10 (5.4) 9 (22.0) 
 Distant 9 (3.1) 5 (7.6) 7 (3.8) 4 (9.8) 
 Unknown 5 (1.7) 1 (1.5) 3 (1.6) 2 (4.9) 
Pa 0.266 <0.001 
Location 
 Face 59 (20.5) 16 (24.2) 13 (7.0) 4 (9.8) 
 Trunk 129 (44.8) 17 (25.8) 55 (29.6) 10 (24.4) 
 Upper limbs, including shoulders 72 (25.0) 15 (22.7) 69 (37.1) 11 (26.8) 
 Lower limbs, including hips 18 (6.3) 13 (19.7) 45 (24.2) 11 (26.8) 
 Skin, NOS 10 (3.5) 5 (7.6) 4 (2.2) 5 (12.2) 
Pa <0.001 0.680 
MIS 
 No. eligible men 18,594 48,906 20,695 52,312 
 Total person-years 230,462.4 605,912.5 265,774.2 675,143.8 
 No. of cases 218 40 120 34 
Histology 
 Melanoma, NOS 127 (58.3) 21 (52.5) 68 (56.7) 17 (50.0) 
 Nodular melanoma 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
 Lentigo maligna melanoma 72 (33.0) 17 (42.5) 45 (37.5) 13 (38.2) 
 Superficial spreading melanoma 14 (6.4) 2 (5.0) 5 (4.2) 2 (5.9) 
 Acral lentingious melanoma 1 (0.5) 0 (0.0) 0 (0) 2 (5.9) 
 Other 4 (1.8) 0 (0.0) 2 (1.7) 0 (0.0) 
Pa 0.779 0.068 
Location 
 Face 77 (35.3) 18 (45.0) 26 (21.7) 14 (41.2) 
 Trunk 84 (38.5) 14 (35.0) 40 (33.3) 5 (14.7) 
 Upper limbs, including shoulders 47 (21.6) 6 (15.0) 35 (29.2) 6 (17.7) 
 Lower limbs, including hips 10 (4.6) 2 (5.0) 19 (15.8) 9 (26.5) 
 Skin, NOS 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
Pa 0.639 0.019 
MalesFemales
WhitesNon-whites/multiracialsWhitesNon-whites/multiracials
IMM 
No. eligible 18,612 48,909 20,713 52,320 
 Total person-years 231,927.6 606,194.1 266,832.2 675,453.8 
 No. of cases 288 66 186 41 
Race 
 Japanese American  12 (18.2)  16 (39.0) 
 Latino American  30 (45.5)  10 (24.4) 
 Multiracials  20 (30.3)  15 (36.6) 
 Native Hawaiian  4 (6.1)  0 (0.0) 
 Whites 288 (100) 0 (0.0) 186 (100) 0 (0.0) 
Histology 
 Melanoma, NOS 179 (62.2) 33 (50.0) 96 (51.6) 17 (41.5) 
 Nodular melanoma 18 (6.3) 5 (7.6) 9 (4.8) 5 (12.2) 
 Lentigo maligna melanoma 23 (8.0) 10 (15.2) 11 (5.9) 2 (4.9) 
 Superficial spreading melanoma 57 (19.8) 9 (13.6) 61 (32.8) 9 (22.0) 
 Acral lentiginous melanoma 2 (0.7) 4 (6.1) 0 (0.0) 6 (14.6) 
 Other 9 (3.1) 5 (7.6) 9 (4.8) 2 (4.9) 
Pa 0.015 <0.001 
Stage 
 Localized 259 (89.9) 57 (86.4) 166 (89.3) 26 (63.4) 
 Regional 15 (5.2) 3 (4.6) 10 (5.4) 9 (22.0) 
 Distant 9 (3.1) 5 (7.6) 7 (3.8) 4 (9.8) 
 Unknown 5 (1.7) 1 (1.5) 3 (1.6) 2 (4.9) 
Pa 0.266 <0.001 
Location 
 Face 59 (20.5) 16 (24.2) 13 (7.0) 4 (9.8) 
 Trunk 129 (44.8) 17 (25.8) 55 (29.6) 10 (24.4) 
 Upper limbs, including shoulders 72 (25.0) 15 (22.7) 69 (37.1) 11 (26.8) 
 Lower limbs, including hips 18 (6.3) 13 (19.7) 45 (24.2) 11 (26.8) 
 Skin, NOS 10 (3.5) 5 (7.6) 4 (2.2) 5 (12.2) 
Pa <0.001 0.680 
MIS 
 No. eligible men 18,594 48,906 20,695 52,312 
 Total person-years 230,462.4 605,912.5 265,774.2 675,143.8 
 No. of cases 218 40 120 34 
Histology 
 Melanoma, NOS 127 (58.3) 21 (52.5) 68 (56.7) 17 (50.0) 
 Nodular melanoma 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
 Lentigo maligna melanoma 72 (33.0) 17 (42.5) 45 (37.5) 13 (38.2) 
 Superficial spreading melanoma 14 (6.4) 2 (5.0) 5 (4.2) 2 (5.9) 
 Acral lentingious melanoma 1 (0.5) 0 (0.0) 0 (0) 2 (5.9) 
 Other 4 (1.8) 0 (0.0) 2 (1.7) 0 (0.0) 
Pa 0.779 0.068 
Location 
 Face 77 (35.3) 18 (45.0) 26 (21.7) 14 (41.2) 
 Trunk 84 (38.5) 14 (35.0) 40 (33.3) 5 (14.7) 
 Upper limbs, including shoulders 47 (21.6) 6 (15.0) 35 (29.2) 6 (17.7) 
 Lower limbs, including hips 10 (4.6) 2 (5.0) 19 (15.8) 9 (26.5) 
 Skin, NOS 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
Pa 0.639 0.019 

NOTE: All values are expressed as n (%).

aP values exclude NOS and other.

Table 3 presents both the minimally and fully adjusted RRs for IMM among whites and non-whites/multiracials. We found that the direction of associations were consistent between the minimally and fully adjusted models. In non-whites/multiracials, the association with ever-sunburned status was slightly attenuated where the association was no longer significant in the fully adjusted model (P = 0.305). With the exception of age at cohort entry (Pheterogeneity = 0.062) and hair and eye color (Pheterogeneity ≤ 0.016), we found that the other IMM risk factors did not differ between whites and non-whites/multiracials (Pheterogeneity ≥ 0.10). Age at cohort entry was suggestive of greater IMM risk among non-white/multiracials and lighter hair and eye colors were associated with greater IMM risk among non-white/multiracials.

Table 3.

RRs for IMM among whites and non-whites/multiracials recruited to the MEC study, 1993–1996

WhitesNon-whites/multiracials
CharacteristicsCasesRR (95% CI)aRR (95% CI)bCasesRR (95% CI)aRR (95% CI)bPheterogeneityc
Study site 
 California 70 1.00 1.00 45 1.00 1.00 0.600 
 Hawaii 402 2.42 (1.97–2.98) 2.01 (1.55–2.60) 52 1.75 (0.89–3.43) 1.82 (0.93–3.60)  
P  <0.001 <0.001  0.107 0.083  
Sex 
 Male 286 1.00 1.00 62 1.00 1.00 0.582 
 Female 186 0.62 (0.53–0.74) 0.59 (0.49–0.71) 35 0.52 (0.34–0.78) 0.47 (0.31–0.72)  
P  <0.001 <0.001  0.002 0.001  
Education 
 ≤High school 61 1.00 1.00 42 1.00 1.00 0.472 
 Some college 137 2.70 (2.10–3.46) 1.63 (1.20–2.21) 34 1.85 (1.16–2.96) 1.79 (1.12–2.87)  
 ≥College 274 4.40 (3.49–5.56) 2.08 (1.57–2.77) 21 1.74 (1.00–3.02) 1.60 (0.91–2.80)  
Ptrend  <0.001 <0.001  0.019 0.046  
Age 
 1-y increase  1.04 (1.03–1.05) 1.03 (1.02–1.05)  1.06 (1.03–1.09) 1.06 (1.03–1.08) 0.062 
P  <0.001 <0.001  <0.001 <0.001  
Hair color 
 Black/medium dark brown 208 1.00 1.00 77 1.00 1.00 0.016 
 Light brown 161 1.68 (1.37–2.06) 1.57 (1.28–1.93) 16 2.56 (1.46–4.50) 2.33 (1.32–4.11)  
 Blonde 79 1.58 (1.22–2.05) 1.40 (1.08–1.82) 3.17 (0.77–13.1) 2.61 (0.63–10.8)  
 Red 24 2.23 (1.46–3.40) 1.73 (1.13–2.65) 6.39 (1.55–26.4) 5.12 (1.23–21.4)  
Ptrend  <0.001 <0.001  <0.001 <0.001  
Eye color 
 Dark (black/dark brown) 138 1.00 1.00 76 1.00 1.00 0.005 
 Light (blue, gray, and green) 334 1.51 (1.24–1.85) 1.34 (1.09–1.64) 21 3.39 (2.03–5.66) 2.99 (1.76–5.06)  
P  <0.001 0.005  <0.001 <0.001  
Tanning ability 
 Deeply 79 1.00 1.00 20 1.00 1.00 0.803 
 Moderately 271 1.44 (1.12–1.84) 1.33 (1.03–1.71) 56 1.59 (0.95–2.66) 1.59 (0.95–2.66)  
 Lightly 106 2.05 (1.53–2.75) 1.69 (1.26–2.27) 21 2.36 (1.26–4.40) 2.37 (1.27–4.42)  
 Not at all 16 2.68 (1.56–4.60) 2.07 (1.20–3.57)    
Ptrend  <0.001 <0.001  0.071 0.066  
Skin reaction to sunlight 
 No effect or tans 51 1.00 1.00 36 1.00 1.00 0.362 
 Mild burn, then tans 233 1.79 (1.32–2.43) 1.55 (1.14–2.11) 47 1.52 (0.98–2.36) 1.43 (0.92–2.23)  
 Severe burns without blistering 129 2.61 (1.89–3.62) 2.03 (1.45–2.83) 10 1.44 (0.71–2.92) 1.21 (0.59–2.49)  
 Severe burning with blistering 59 2.42 (1.66–3.53) 1.73 (1.17–2.55) 1.38 (0.49–3.90) 1.00 (0.34–2.93)  
Ptrend  <0.001 0.001  0.152 0.51  
Sunburn susceptibility phenotype index 
 0–1 40 1.00 1.00 26 1.00 1.00 0.048 
 2–3 163 1.59 (1.12–2.24) 1.44 (1.02–2.04) 56 2.13 (1.33–3.40) 2.06 (1.29–3.30)  
 4–5 161 2.20 (1.56–3.12) 1.81 (1.27–2.57) 10 2.68 (1.28–5.64) 2.30 (1.07–4.92)  
 6–7 77 2.86 (1.95–4.20) 2.13 (1.44–3.16) 7.75 (2.66–22.6) 5.82 (1.92–17.6)  
 >7 31 4.35 (2.71–6.98) 2.97 (1.84–4.82) 15.8 (2.10–118) 10.3 (1.32–80.4)  
Ptrend  <0.001 <0.001  <0.001 <0.001  
Ever-sunburnedd 
 No 113 1.00 1.00 63 1.00 1.00 0.655 
 Yes 359 1.87 (1.51–2.31) 1.52 (1.22–1.89) 34 1.56 (1.02–2.38) 1.26 (0.81–1.98)  
P  <0.001 <0.001  0.04 0.305  
Lifetime number of sunburnsd,e 
 No sunburn 113 1.00 1.00 63 1.00 1.00 0.711 
 ≤3 sunburns 216 1.70 (1.36–2.13) 1.45 (1.15–1.82) 21 1.42 (0.86–2.34) 1.18 (0.71–1.98)  
 >3 sunburns 137 1.95 (1.52–2.50) 1.45 (1.12–1.88) 13 2.04 (1.11–3.76) 1.60 (0.85–3.01)  
Ptrend  <0.001 0.004  0.014 0.148  
Age of first sunburnd,e 
 Never sunburned 113 1.00 1.00 63 1.00 1.00 0.720 
 <13 y 110 2.31 (1.78–3.00) 1.69 (1.28–2.22) 1.67 (0.67–4.21) 1.18 (0.45–3.08)  
 13–17 y 96 1.71 (1.31–2.24) 1.39 (1.05–1.83) 1.68 (0.79–3.53) 1.35 (0.63–2.87)  
 ≥18 y 146 1.54 (1.21–1.97) 1.35 (1.06–1.72) 21 1.56 (0.95–2.57) 1.31 (0.79–2.19)  
Ptrend  0.003 0.068  0.046 0.25  
Family history of melanomad 
 No 458 1.00 1.00 96 1.00 1.00 0.808 
 Yes 14 2.47 (1.45–4.21) 2.04 (1.19–3.48) 3.27 (0.45–23.64) 2.55 (0.35–18.7)  
P  0.001 0.009  0.241 0.357  
History of NMSCd 
 No 337 1.00 1.00 91 1.00 1.00 0.336 
 Yes 135 2.51 (2.04–3.08) 2.19 (1.78–2.70) 3.97 (1.71–9.21) 2.98 (1.25–7.10)  
P  <0.001 <0.001  0.001 0.014  
WhitesNon-whites/multiracials
CharacteristicsCasesRR (95% CI)aRR (95% CI)bCasesRR (95% CI)aRR (95% CI)bPheterogeneityc
Study site 
 California 70 1.00 1.00 45 1.00 1.00 0.600 
 Hawaii 402 2.42 (1.97–2.98) 2.01 (1.55–2.60) 52 1.75 (0.89–3.43) 1.82 (0.93–3.60)  
P  <0.001 <0.001  0.107 0.083  
Sex 
 Male 286 1.00 1.00 62 1.00 1.00 0.582 
 Female 186 0.62 (0.53–0.74) 0.59 (0.49–0.71) 35 0.52 (0.34–0.78) 0.47 (0.31–0.72)  
P  <0.001 <0.001  0.002 0.001  
Education 
 ≤High school 61 1.00 1.00 42 1.00 1.00 0.472 
 Some college 137 2.70 (2.10–3.46) 1.63 (1.20–2.21) 34 1.85 (1.16–2.96) 1.79 (1.12–2.87)  
 ≥College 274 4.40 (3.49–5.56) 2.08 (1.57–2.77) 21 1.74 (1.00–3.02) 1.60 (0.91–2.80)  
Ptrend  <0.001 <0.001  0.019 0.046  
Age 
 1-y increase  1.04 (1.03–1.05) 1.03 (1.02–1.05)  1.06 (1.03–1.09) 1.06 (1.03–1.08) 0.062 
P  <0.001 <0.001  <0.001 <0.001  
Hair color 
 Black/medium dark brown 208 1.00 1.00 77 1.00 1.00 0.016 
 Light brown 161 1.68 (1.37–2.06) 1.57 (1.28–1.93) 16 2.56 (1.46–4.50) 2.33 (1.32–4.11)  
 Blonde 79 1.58 (1.22–2.05) 1.40 (1.08–1.82) 3.17 (0.77–13.1) 2.61 (0.63–10.8)  
 Red 24 2.23 (1.46–3.40) 1.73 (1.13–2.65) 6.39 (1.55–26.4) 5.12 (1.23–21.4)  
Ptrend  <0.001 <0.001  <0.001 <0.001  
Eye color 
 Dark (black/dark brown) 138 1.00 1.00 76 1.00 1.00 0.005 
 Light (blue, gray, and green) 334 1.51 (1.24–1.85) 1.34 (1.09–1.64) 21 3.39 (2.03–5.66) 2.99 (1.76–5.06)  
P  <0.001 0.005  <0.001 <0.001  
Tanning ability 
 Deeply 79 1.00 1.00 20 1.00 1.00 0.803 
 Moderately 271 1.44 (1.12–1.84) 1.33 (1.03–1.71) 56 1.59 (0.95–2.66) 1.59 (0.95–2.66)  
 Lightly 106 2.05 (1.53–2.75) 1.69 (1.26–2.27) 21 2.36 (1.26–4.40) 2.37 (1.27–4.42)  
 Not at all 16 2.68 (1.56–4.60) 2.07 (1.20–3.57)    
Ptrend  <0.001 <0.001  0.071 0.066  
Skin reaction to sunlight 
 No effect or tans 51 1.00 1.00 36 1.00 1.00 0.362 
 Mild burn, then tans 233 1.79 (1.32–2.43) 1.55 (1.14–2.11) 47 1.52 (0.98–2.36) 1.43 (0.92–2.23)  
 Severe burns without blistering 129 2.61 (1.89–3.62) 2.03 (1.45–2.83) 10 1.44 (0.71–2.92) 1.21 (0.59–2.49)  
 Severe burning with blistering 59 2.42 (1.66–3.53) 1.73 (1.17–2.55) 1.38 (0.49–3.90) 1.00 (0.34–2.93)  
Ptrend  <0.001 0.001  0.152 0.51  
Sunburn susceptibility phenotype index 
 0–1 40 1.00 1.00 26 1.00 1.00 0.048 
 2–3 163 1.59 (1.12–2.24) 1.44 (1.02–2.04) 56 2.13 (1.33–3.40) 2.06 (1.29–3.30)  
 4–5 161 2.20 (1.56–3.12) 1.81 (1.27–2.57) 10 2.68 (1.28–5.64) 2.30 (1.07–4.92)  
 6–7 77 2.86 (1.95–4.20) 2.13 (1.44–3.16) 7.75 (2.66–22.6) 5.82 (1.92–17.6)  
 >7 31 4.35 (2.71–6.98) 2.97 (1.84–4.82) 15.8 (2.10–118) 10.3 (1.32–80.4)  
Ptrend  <0.001 <0.001  <0.001 <0.001  
Ever-sunburnedd 
 No 113 1.00 1.00 63 1.00 1.00 0.655 
 Yes 359 1.87 (1.51–2.31) 1.52 (1.22–1.89) 34 1.56 (1.02–2.38) 1.26 (0.81–1.98)  
P  <0.001 <0.001  0.04 0.305  
Lifetime number of sunburnsd,e 
 No sunburn 113 1.00 1.00 63 1.00 1.00 0.711 
 ≤3 sunburns 216 1.70 (1.36–2.13) 1.45 (1.15–1.82) 21 1.42 (0.86–2.34) 1.18 (0.71–1.98)  
 >3 sunburns 137 1.95 (1.52–2.50) 1.45 (1.12–1.88) 13 2.04 (1.11–3.76) 1.60 (0.85–3.01)  
Ptrend  <0.001 0.004  0.014 0.148  
Age of first sunburnd,e 
 Never sunburned 113 1.00 1.00 63 1.00 1.00 0.720 
 <13 y 110 2.31 (1.78–3.00) 1.69 (1.28–2.22) 1.67 (0.67–4.21) 1.18 (0.45–3.08)  
 13–17 y 96 1.71 (1.31–2.24) 1.39 (1.05–1.83) 1.68 (0.79–3.53) 1.35 (0.63–2.87)  
 ≥18 y 146 1.54 (1.21–1.97) 1.35 (1.06–1.72) 21 1.56 (0.95–2.57) 1.31 (0.79–2.19)  
Ptrend  0.003 0.068  0.046 0.25  
Family history of melanomad 
 No 458 1.00 1.00 96 1.00 1.00 0.808 
 Yes 14 2.47 (1.45–4.21) 2.04 (1.19–3.48) 3.27 (0.45–23.64) 2.55 (0.35–18.7)  
P  0.001 0.009  0.241 0.357  
History of NMSCd 
 No 337 1.00 1.00 91 1.00 1.00 0.336 
 Yes 135 2.51 (2.04–3.08) 2.19 (1.78–2.70) 3.97 (1.71–9.21) 2.98 (1.25–7.10)  
P  <0.001 <0.001  0.001 0.014  

aModel adjusted for age, study site, race/ethnic groups, part-white status, sex, and education.

bAdditionally adjusted for ever-sunburned status, family history of melanoma, and personal history of NMSC.

cTests heterogeneity between whites and non-whites/multiracials.

dAlso adjusted for sunburn susceptibility phenotype index.

eSix white IMM cases with missing information about lifetime number of sunburns; seven white IMM cases with missing information about age of first sunburn.

Table 4 presents both the minimally and fully adjusted RRs for MIS among whites and non-whites/multiracials. We found that the RRs for MIS between whites and non-whites/multiracials also differed for geographic location and education (Pheterogeneity ≤ 0.015), where both of these factors were not associated with MIS in non-whites/multiracials. The comparison of risk factors between IMM and MIS within whites and within non-whites/multiracials showed no difference in associations (Pheterogeneity > 0.10; data not shown), although the RRs for age at cohort entry and sunburn susceptible phenotypes appear stronger for IMM than MIS.

Table 4.

RRs for MIS among whites and non-whites/multiracials recruited to the MEC study, 1993–1996

WhitesNon-whites/multiracials
CharacteristicsCasesRR (95% CI)aRR (95% CI)bCasesRR (95% CI)aRR (95% CI)bPheterogeneityc
Study site 
 California 37 1.00 1.00 33 1.00 1.00 <0.001 
 Hawaii 300 3.13 (2.20–4.44) 2.88 (2.03–4.09) 39 1.06 (0.54–2.09) 1.07 (0.54–2.12)  
 P  <0.001 <0.001  0.867 0.839  
Sex 
 Male 217 1.00 1.00 40 1.00 1.00 0.309 
 Female 120 0.56 (0.45–0.70) 0.53 (0.42–0.66) 32 0.71 (0.44–1.13) 0.68 (0.42–1.08)  
P  <0.001 <0.001  0.143 0.103  
Education 
 ≤High school 42 1.00 1.00 37 1.00 1.00 0.015 
 Some college 98 1.90 (1.32–2.73) 1.68 (1.16–2.42) 22 1.18 (0.68–2.05) 1.14 (0.65–1.98)  
 ≥College 197 2.50 (1.78–3.50) 2.11 (1.50–2.97) 13 0.91 (0.46–1.78) 0.84 (0.43–1.65)  
Ptrend  <0.001 <0.001  0.906 0.724  
Age 
 1-y increase  1.04 (1.03–1.05) 1.03 (1.02–1.05)  1.03 (1.01–1.06) 1.03 (1.00–1.06) 0.184 
P  <0.001 <0.001  0.028 0.046  
Hair color 
 Black/medium dark brown 163 1.00 1.00 60 1.00 1.00 0.002 
 Light brown 100 1.32 (1.03–1.70) 1.25 (0.97–1.60) 1.91 (0.83–4.38) 1.77 (0.77–4.07)  
 Blonde 64 1.65 (1.23–2.20) 1.48 (1.11–1.98) 15.0 (5.76–38.9) 12.4 (4.64–33.0)  
 Red 10 1.20 (0.64–2.28) 0.96 (0.50–1.82)    
Ptrend  0.002 0.036  <0.001 0.001  
Eye color 
 Dark (black/dark brown) 103 1.00 1.00 59 1.00 1.00 0.002 
 Light (blue, gray, and green) 234 1.40 (1.11–1.76) 1.25 (0.99–1.59) 13 4.44 (2.28–8.66) 3.97 (2.00–7.88)  
P  0.005 0.059  <0.001 <0.001  
Tanning ability 
 Deeply 64 1.00 1.00 21 1.00 1.00 0.804 
 Moderately 204 1.35 (1.02–1.78) 1.25 (0.94–1.66) 36 0.95 (0.55–1.63) 0.95 (0.55–1.64)  
 Lightly 61 1.51 (1.06–2.15) 1.26 (0.88–1.80) 15 1.52 (0.77–2.98) 1.53 (0.78–3.00)  
 Not at all 1.76 (0.84–3.69) 1.39 (0.66–2.92)    
Ptrend  0.012 0.166  0.708 0.694  
Skin reaction to sunlight 
 No effect or tans 45 1.00 1.00 33 1.00 1.00 0.963 
 Mild burn, then tans 174 1.51 (1.09–2.10) 1.32 (0.95–1.84) 24 0.82 (0.48–1.39) 0.79 (0.46–1.35)  
 Severe burns without blistering 83 1.92 (1.33–2.76) 1.51 (1.04–2.00) 12 1.76 (0.90–3.44) 1.57 (0.79–3.12)  
 Severe burning with blistering 35 1.69 (1.08–2.63) 1.23 (0.78–1.94) 1.14 (0.35–3.74) 0.93 (0.27–3.23)  
Ptrend  0.002 0.206  0.381 0.647  
Sunburn susceptibility phenotype index 
 0–1 35 1.00 1.00 30 1.00 1.00 0.256 
 2–3 122 1.36 (0.93–1.97) 1.23 (0.85–1.80) 31 1.00 (0.60–1.66) 0.98 (0.59–1.63)  
 4–5 119 1.86 (1.27–2.71) 1.54 (1.05–2.26) 2.13 (0.96–4.76) 1.91 (0.84–4.38)  
 6–7 44 1.90 (1.22–2.97) 1.44 (0.92–2.28) 6.63 (1.96–22.5) 5.22 (1.47–18.6)  
 >7 17 2.82 (1.58–5.06) 1.98 (1.09–3.58)    
Ptrend  <0.001 0.01  0.306 0.091  
Ever-sunburned d 
 No 85 1.00 1.00 52 1.00 1.00 0.311 
 Yes 252 1.74 (1.36–2.23) 1.50 (1.16–1.94) 20 1.24 (0.73–2.09) 1.00 (0.58–1.74)  
P  <0.001 0.002  0.422 0.992  
Lifetime number of sunburnsd 
 No sunburns 85 1.00 1.00 52 1.00 1.00 0.233 
 ≤3 sunburns 138 1.53 (1.17–2.01) 1.38 (1.05–1.82) 14 1.26 (0.69–2.28) 1.03 (0.56–1.92)  
 >3 sunburns 114 2.25 (1.70–2.99) 1.85 (1.38–2.48) 1.29 (0.55–3.04) 1.00 (0.41–2.41)  
Ptrend  <0.001 <0.001  0.401 0.962  
Age of first sunburnd,e 
 Never sunburned 85 1.00 1.00 52 1.00 1.00 0.395 
 <13 y 73 2.10 (1.53–2.88) 1.69 (1.22–2.35) 2.79 (1.18–6.59) 2.10 (0.87–5.11)  
 13–17 y 82 2.04 (1.50–2.77) 1.77 (1.30–2.41) 1.37 (0.54–3.46) 1.10 (0.43–2.82)  
 ≥18 y 96 1.43 (1.07–1.92) 1.31 (0.97–1.75) 0.91 (0.44–1.85) 0.76 (0.36–1.57)  
Ptrend  0.014 0.082  0.918 0.55  
Family history of melanomad 
 No 330 1.00 1.00 71 1.00 1.00 0.379 
 Yes 1.72 (0.81–3.65) 1.48 (0.70–3.14) 5.64 (0.78–41.0) 5.56 (0.76–40.6)  
P  0.155 0.304  0.087 0.091  
History of NMSCd 
 No 246 1.00 1.00 67 1.00 1.00 0.099 
 Yes 91 2.31 (1.80–2.95) 2.12 (1.65–2.72) 6.15 (2.44–15.5) 5.10 (1.98–13.2)  
P  <0.001 <0.001  <0.001 0.001  
WhitesNon-whites/multiracials
CharacteristicsCasesRR (95% CI)aRR (95% CI)bCasesRR (95% CI)aRR (95% CI)bPheterogeneityc
Study site 
 California 37 1.00 1.00 33 1.00 1.00 <0.001 
 Hawaii 300 3.13 (2.20–4.44) 2.88 (2.03–4.09) 39 1.06 (0.54–2.09) 1.07 (0.54–2.12)  
 P  <0.001 <0.001  0.867 0.839  
Sex 
 Male 217 1.00 1.00 40 1.00 1.00 0.309 
 Female 120 0.56 (0.45–0.70) 0.53 (0.42–0.66) 32 0.71 (0.44–1.13) 0.68 (0.42–1.08)  
P  <0.001 <0.001  0.143 0.103  
Education 
 ≤High school 42 1.00 1.00 37 1.00 1.00 0.015 
 Some college 98 1.90 (1.32–2.73) 1.68 (1.16–2.42) 22 1.18 (0.68–2.05) 1.14 (0.65–1.98)  
 ≥College 197 2.50 (1.78–3.50) 2.11 (1.50–2.97) 13 0.91 (0.46–1.78) 0.84 (0.43–1.65)  
Ptrend  <0.001 <0.001  0.906 0.724  
Age 
 1-y increase  1.04 (1.03–1.05) 1.03 (1.02–1.05)  1.03 (1.01–1.06) 1.03 (1.00–1.06) 0.184 
P  <0.001 <0.001  0.028 0.046  
Hair color 
 Black/medium dark brown 163 1.00 1.00 60 1.00 1.00 0.002 
 Light brown 100 1.32 (1.03–1.70) 1.25 (0.97–1.60) 1.91 (0.83–4.38) 1.77 (0.77–4.07)  
 Blonde 64 1.65 (1.23–2.20) 1.48 (1.11–1.98) 15.0 (5.76–38.9) 12.4 (4.64–33.0)  
 Red 10 1.20 (0.64–2.28) 0.96 (0.50–1.82)    
Ptrend  0.002 0.036  <0.001 0.001  
Eye color 
 Dark (black/dark brown) 103 1.00 1.00 59 1.00 1.00 0.002 
 Light (blue, gray, and green) 234 1.40 (1.11–1.76) 1.25 (0.99–1.59) 13 4.44 (2.28–8.66) 3.97 (2.00–7.88)  
P  0.005 0.059  <0.001 <0.001  
Tanning ability 
 Deeply 64 1.00 1.00 21 1.00 1.00 0.804 
 Moderately 204 1.35 (1.02–1.78) 1.25 (0.94–1.66) 36 0.95 (0.55–1.63) 0.95 (0.55–1.64)  
 Lightly 61 1.51 (1.06–2.15) 1.26 (0.88–1.80) 15 1.52 (0.77–2.98) 1.53 (0.78–3.00)  
 Not at all 1.76 (0.84–3.69) 1.39 (0.66–2.92)    
Ptrend  0.012 0.166  0.708 0.694  
Skin reaction to sunlight 
 No effect or tans 45 1.00 1.00 33 1.00 1.00 0.963 
 Mild burn, then tans 174 1.51 (1.09–2.10) 1.32 (0.95–1.84) 24 0.82 (0.48–1.39) 0.79 (0.46–1.35)  
 Severe burns without blistering 83 1.92 (1.33–2.76) 1.51 (1.04–2.00) 12 1.76 (0.90–3.44) 1.57 (0.79–3.12)  
 Severe burning with blistering 35 1.69 (1.08–2.63) 1.23 (0.78–1.94) 1.14 (0.35–3.74) 0.93 (0.27–3.23)  
Ptrend  0.002 0.206  0.381 0.647  
Sunburn susceptibility phenotype index 
 0–1 35 1.00 1.00 30 1.00 1.00 0.256 
 2–3 122 1.36 (0.93–1.97) 1.23 (0.85–1.80) 31 1.00 (0.60–1.66) 0.98 (0.59–1.63)  
 4–5 119 1.86 (1.27–2.71) 1.54 (1.05–2.26) 2.13 (0.96–4.76) 1.91 (0.84–4.38)  
 6–7 44 1.90 (1.22–2.97) 1.44 (0.92–2.28) 6.63 (1.96–22.5) 5.22 (1.47–18.6)  
 >7 17 2.82 (1.58–5.06) 1.98 (1.09–3.58)    
Ptrend  <0.001 0.01  0.306 0.091  
Ever-sunburned d 
 No 85 1.00 1.00 52 1.00 1.00 0.311 
 Yes 252 1.74 (1.36–2.23) 1.50 (1.16–1.94) 20 1.24 (0.73–2.09) 1.00 (0.58–1.74)  
P  <0.001 0.002  0.422 0.992  
Lifetime number of sunburnsd 
 No sunburns 85 1.00 1.00 52 1.00 1.00 0.233 
 ≤3 sunburns 138 1.53 (1.17–2.01) 1.38 (1.05–1.82) 14 1.26 (0.69–2.28) 1.03 (0.56–1.92)  
 >3 sunburns 114 2.25 (1.70–2.99) 1.85 (1.38–2.48) 1.29 (0.55–3.04) 1.00 (0.41–2.41)  
Ptrend  <0.001 <0.001  0.401 0.962  
Age of first sunburnd,e 
 Never sunburned 85 1.00 1.00 52 1.00 1.00 0.395 
 <13 y 73 2.10 (1.53–2.88) 1.69 (1.22–2.35) 2.79 (1.18–6.59) 2.10 (0.87–5.11)  
 13–17 y 82 2.04 (1.50–2.77) 1.77 (1.30–2.41) 1.37 (0.54–3.46) 1.10 (0.43–2.82)  
 ≥18 y 96 1.43 (1.07–1.92) 1.31 (0.97–1.75) 0.91 (0.44–1.85) 0.76 (0.36–1.57)  
Ptrend  0.014 0.082  0.918 0.55  
Family history of melanomad 
 No 330 1.00 1.00 71 1.00 1.00 0.379 
 Yes 1.72 (0.81–3.65) 1.48 (0.70–3.14) 5.64 (0.78–41.0) 5.56 (0.76–40.6)  
P  0.155 0.304  0.087 0.091  
History of NMSCd 
 No 246 1.00 1.00 67 1.00 1.00 0.099 
 Yes 91 2.31 (1.80–2.95) 2.12 (1.65–2.72) 6.15 (2.44–15.5) 5.10 (1.98–13.2)  
P  <0.001 <0.001  <0.001 0.001  

aModel adjusted for age, study site, race/ethnic groups, part-white status, sex, and education.

bAdditionally adjusted for ever-sunburned status, family history of melanoma, and personal history of NMSC.

cTests heterogeneity between whites and non-whites/multiracials.

dAlso adjusted for sunburn susceptibility phenotype index.

eOne white MIS case with missing information about age of first sunburn.

To our knowledge, this is the first prospective study to investigate tumor characteristics and risk factors for malignant melanoma in non-whites other than African Americans and to compare these factors between this population and whites.

We found that non-white/multiracial males had a lower proportion of IMM on the anatomic trunk and non-white/multiracial females were more likely to present with later stage disease. Previous studies using cancer registry data have also reported that non-whites were more likely to present with tumors on the lower extremities, of ALM histologic subtype and at later stage of disease (17–20, 23–28). On the basis of these observations, it has been suggested that UVR exposure may play less of an etiologic factor in melanoma development in non-whites.

To examine this, first, we confirmed the associations for established risk factors (14, 15, 29–32): latitudinal location (Hawaii), higher education, male sex, age, lighter hair and eye color, propensity to sunburn phenotypes, ever-sunburned status, personal history of NMSC, and family history of melanoma, with risk of IMM and MIS in our white population. Here, we showed that the association of these risk factors for IMM did not differ between whites and non-whites/multiracials. All factors, with the exception of latitudinal location and higher education, were associated with an increased risk of MIS in non-whites/multiracials. These findings suggest that similar to whites, phenotypes exhibiting greater susceptibility to sunburn are associated with an increased risk of malignant melanoma in non-white/multiracial populations. Supporting this suggestion, experimental studies have shown that the amount of UVR-related DNA damage did not differ among those with darker skin phototype compared with whites (33). The difference in disease incidence may be partially explained from the observations that among non-whites, the UVR-related DNA damage may have a higher rate of repair (33) and/or may be restricted to the upper layers of skin (34).

Two sun exposure pathways to malignant melanoma have been postulated (35–37), acute and chronic sun exposure. The former is characterized by younger age at diagnosis, lesions often located on the trunk for men and lower limbs for females, and superficial spreading histologic subtype (35, 38–45). Alternatively, tumors that may arise from chronic sun exposure have been associated with history of NMSC, older age, lesions found on the face and neck, and the lentigo maligna melanoma (LMM) histologic subtype (35, 38–40, 42, 44). In non-whites/multiracials, the distribution of tumor characteristics, associations found with age and no clear association with ever-sunburned status suggests that in this population, chronic sun exposure may be more predictive of malignant melanoma risk than acute exposure. However, because of the sizable number of unspecified tumor histologies, we were unable to confirm the proportion of LMM cases to support the chronic sun exposure hypothesis. In addition, test for heterogeneity between whites and non-whites/multiracials showed no difference in risk estimates for ever-sunburned status, suggesting that the role of acute sun exposure cannot be ruled out. The sample size may have been too small to detect a modest effect with ever-sunburned status, or heterogeneity of risk estimates between these 2 racial groups may have been insufficient. Studies with measures of chronic sun exposure, such as degree of solar keratoses (36) or tumor characteristics that have been associated with chronic exposure, such as TP53-positive status (46), would help to clarify the association of sun exposure patterns with malignant melanoma risk in non-whites/multiracials.

In contrast, chronic sun exposure may promote epithelial thickening and protect melanocytes from UVR damage (44, 47): in occupational studies, workers with chronic sun exposure have lower risk of melanoma (37, 48) than those with intermittent exposure (41, 49). Although occupational information exists for our participants, the sample size was too small to evaluate a potential difference in malignant melanoma incidence among non-whites/multiracials with occupational variations of sun exposure (e.g., office vs. farm work). Further study to investigate the association with cumulated lifetime chronic sun exposure is needed.

The malignant melanoma risk estimates for sunburn susceptible phenotypic score and hair and eye color differed between non-whites/multiracials and whites, where malignant melanoma risk was greater among non-whites/multiracials with lighter hair and eye color. This may be due to the differences within this group. For instance, in our study, the risk estimates for hair and eye color likely reflect a comparison of Latinos and multiracials, who have fairer hair and eye colors, with Japanese Americans, who have uniform dark hair and eyes. A study conducted by Wagner and colleagues found that in Hispanics (n = 45) and East Asians (n = 15), melanin content, as measured by Adjusted Melanin Index, was similar between these 2 populations (P = 0.371); however, tanning response, as measured by Melanogenic Dose–Response, was higher among East Asians than Hispanics (P < 0.001; ref. 50), suggesting that East Asians may be a lower risk of disease than Hispanics. In our study, we did not detect heterogeneity of sunburn susceptibility phenotypes within non-whites/multiracials. However, in future studies, quantitative measurements such as these may improve accuracy and comparability within a multiethnic study population. In addition, adjustment for ancestral markers and/or investigating the association of polymorphisms in MC1R, which has been found to be associated with melanoma risk independently of these constitutional factors (51–53), may decrease residual confounding by race and improve risk predictability in populations that present with homogenous susceptibility to sunburn phenotypes. However, these markers were not available for this study.

Studies have found that non-whites are more likely to be diagnosed with later stage disease (17, 18, 27) and thereby have decreased disease survival. Risk factors for MIS may represent risk for early-stage disease, as well as associations with screening behaviors and accessibility to medical care. A case-only study using CCR data found that when accounting for socioeconomic status (SES), as derived from principal component analysis of census block-level data, survival for Asians (P = 0.745) and Hispanics (P = 0.296) did not differ from that for whites (54). In our study, no clear association was found between education and risk of MIS among non-whites/multiracials, suggesting that either higher education, as a proxy for SES, did not improve early detection of disease or delayed diagnosis may have occurred for other reasons, such as perceived lower susceptibility of disease. Further evaluation of SES, education, and screening behaviors would be helpful.

In addition, the risk profile of MIS and IMM may be very different; not all MIS progress to IMM (21, 55). MIS is a form of radial growth phase melanomas; therefore, in situ cases have not been identified in melanomas without a radial growth phase, such as nodular melanoma (55). The molecular pathology of these lesions have shown that MIS have lower frequencies of genetic mutations, such as NRAS and BRAF, and it has been suggested that MIS may acquire additional mutations to progress to invasive disease (56, 57). Our study had the potential to elucidate lifestyle factors that are associated with melanoma screening and risk factors for radial growth phase melanomas among non-whites/multiracials. Although it appeared that the sun susceptibility variables were stronger for IMM than for MIS, when we used the competing risk model, no differences in risk estimates were detected for these 2 outcomes.

This study had some limitations. We were unable to adjust for length of sun exposure and freckling patterns or moles (58). Information about tumor Breslow index was unavailable, which is regrettable as studies have found that Hispanics in California and Pacific peoples in New Zealand may present with greater tumor thickness (7, 9). Residual confounding by constitutional factors may be present. However, the results were similar in models that included a single phenotypic factor, the sunburn susceptible phenotype index, or all phenotypic factors. This suggests that if such confounding was present, it was not captured in the baseline questionnaire data. Because of the limited number of cases in our California and non-white/multiracial populations, we were unable to stratify by state of recruitment. With longer follow-up and additional cases, we will have improved power in analysis of non-whites. Hair and eye color, skin's tanning ability, and skin's reaction to acute sun exposure may also have differential misclassification depending on perceived self-identity and self-image. The high proportion of melanoma histologic subtypes coded as unspecified is a limitation, although rather consistent with what has been reported by other tumor registries (17, 59). Finally, as we were unable to account for the cancer status of participants who moved out of both Hawaii and California, we censored out-of-state migrants at the end of follow-up. This may have introduced bias to our analysis; however, this out-migration has been found to be extremely low (20).

Study strengths include the ability to investigate a range of potential risk factors for malignant melanoma within non-whites/multiracials, the prospective design, and a greater accuracy in measures of race/ethnicity compared with registry data.

In conclusion, this study presents the challenges in identifying risk factors for malignant melanoma in populations with a low incidence of disease. Here, age and susceptibility to sunburn phenotypes were associated with an increased risk of malignant melanoma in non-whites/multiracials. Awareness of these potential risk factors and screening among individuals who are older or have phenotypes that are susceptible to sunburns may help with disease prevention.

No potential conflicts of interests were disclosed.

The authors thank all the MEC members for their participation and commitment.

This work was supported by National Cancer Institute grants: R37 CA54281 (to the MEC study), T32 CA09142 (to S.L. Park) and Career Development Award (K07) CA116543 (to V.W. Setiawan).

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1.
Linos
E
,
Swetter
SM
,
Cockburn
MG
,
Colditz
GA
,
Clarke
CA
. 
Increasing burden of melanoma in the United States
.
J Invest Dermatol
2009
;
129
:
1666
74
.
2.
Lens
MB
,
Dawes
M
. 
Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma
.
Br J Dermatol
2004
;
150
:
179
85
.
3.
Fast Stats: an interactive tool for access to SEER cancer statistics. Surveillance Research Program, National Cancer Institute
.
[cited 2011 Jun 10]. Available from
: http://seer.cancer.gov/faststats.
4.
Parkin
DM
,
Bray
F
,
Ferlay
J
,
Pisani
P
. 
Global cancer statistics, 2002
.
CA Cancer J Clin
2005
;
55
:
74
108
.
5.
Ishihara
K
,
Saida
T
,
Otsuka
F
,
Yamazaki
N
. 
Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update
.
Int J Clin Oncol
2008
;
13
:
33
41
.
6.
Valentin
SM
,
Sanchez
JL
,
Figueroa
LD
,
Nazario
CM
. 
Epidemiology of melanoma in Puerto Rico, 1987–2002
.
P R Health Sci J
2007
;
26
:
343
8
.
7.
Cockburn
MG
,
Zadnick
J
,
Deapen
D
. 
Developing epidemic of melanoma in the Hispanic population of California
.
Cancer
2006
;
106
:
1162
8
.
8.
Hu
S
,
Parmet
Y
,
Allen
G
,
Parker
DF
,
Ma
F
,
Rouhani
P
, et al
Disparity in melanoma: a trend analysis of melanoma incidence and stage at diagnosis among Whites, Hispanics, and Blacks in Florida
.
Arch Dermatol
2009
;
145
:
1369
74
.
9.
Sneyd
MJ
,
Cox
B
. 
Melanoma in Maori, Asian, and Pacific peoples in New Zealand
.
Cancer Epidemiol Biomarkers Prev
2009
;
18
:
1706
13
.
10.
Bentham
G
,
Aase
A
. 
Incidence of malignant melanoma of the skin in Norway, 1955–1989: associations with solar ultraviolet radiation, income and holidays abroad
.
Int J Epidemiol
1996
;
25
:
1132
8
.
11.
Westerdahl
J
,
Olsson
H
,
Ingvar
C
,
Brandt
L
,
Jonsson
PE
,
Moller
T
. 
Southern travelling habits with special reference to tumour site in Swedish melanoma patients
.
Anticancer Res
1992
;
12
:
1539
42
.
12.
Lazovich
D
,
Vogel
RI
,
Berwick
M
,
Weinstock
MA
,
Anderson
KE
,
Warshaw
EM
. 
Indoor tanning and risk of melanoma: a case-control study in a highly exposed population
.
Cancer Epidemiol Biomarkers Prev
2010
;
19
:
1557
68
.
13.
El Ghissassi
F
,
Baan
R
,
Straif
K
,
Grosse
Y
,
Secretan
B
,
Bouvard
V
, et al
A review of human carcinogens–part D: radiation
.
Lancet Oncol
2009
;
10
:
751
2
.
14.
Markovic
SN
,
Erickson
LA
,
Rao
RD
,
Weenig
RH
,
Pockaj
BA
,
Bardia
A
, et al
Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis
.
Mayo Clin Proc
2007
;
82
:
364
80
.
15.
Gruber
SB
,
Armstrong
BK
. 
Cutaneous and ocular melanoma
.
In
:
Schottenfeld
D
,
Fraumeni
JF
,
editors
.
Cancer epidemiology and prevention
New York
:
Oxford Press
; 
2006
. p.
1196
217
.
16.
Howlader
N
,
Noone
AM
,
Krapcho
M
,
Neyman
N
,
Aminou
R
,
Waldron
W
, et al
SEER Cancer Statistics Review, 1975–2008
.
Bethesda, MD
:
National Cancer Institute
.
[cited 2011 Jun 10]. Available from:
http://seer.cancer.gov/csr/1975_2008/,
based on November 2010 SEER data submission, posted to the SEER web site
, 
2011
.
17.
Cress
RD
,
Holly
EA
. 
Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks: an analysis of California cancer registry data, 1988–93
.
Cancer Causes Control
1997
;
8
:
246
52
.
18.
Cormier
JN
,
Xing
Y
,
Ding
M
,
Lee
JE
,
Mansfield
PF
,
Gershenwald
JE
, et al
Ethnic differences among patients with cutaneous melanoma
.
Arch Intern Med
2006
;
166
:
1907
14
.
19.
Hemmings
DE
,
Johnson
DS
,
Tominaga
GT
,
Wong
JH
. 
Cutaneous melanoma in a multiethnic population: is this a different disease?
Arch Surg
2004
;
139
:
968
72
.
20.
Kolonel
LN
,
Henderson
BE
,
Hankin
JH
,
Nomura
AM
,
Wilkens
LR
,
Pike
MC
, et al
A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics
.
Am J Epidemiol
2000
;
151
:
346
57
.
21.
Cohen
LM
. 
Lentigo maligna and lentigo maligna melanoma
.
J Am Acad Dermatol
1995
;
33
:
923
36
.
22.
SEER: Surveillance, Epidemiology, and End Results
.
[cited 2011 Jun 10]. Available from:
http://seer.cancer.gov/.
23.
Sng
J
,
Koh
D
,
Siong
WC
,
Choo
TB
. 
Skin cancer trends among Asians living in Singapore from 1968 to 2006
.
J Am Acad Dermatol
2009
;
61
:
426
32
.
24.
Bergfelt
L
,
Newell
GR
,
Sider
JG
,
Kripke
ML
. 
Incidence and anatomic distribution of cutaneous melanoma among United States Hispanics
.
J Surg Oncol
1989
;
40
:
222
6
.
25.
Black
WC
,
Goldhahn
RT
 Jr
,
Wiggins
C
. 
Melanoma Within a Southwestern Hispanic Population
.
Arch Dermatol
1987
;
123
:
1331
4
.
26.
Shoo
BA
,
Kashani-Sabet
M
. 
Melanoma arising in African-, Asian-, Latino- and Native American populations
.
Semin Cutan Med Surg
2009
;
28
:
96
102
.
27.
Chang
AE
,
Karnell
LH
,
Menck
HR
. 
The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society
.
Cancer
1998
;
83
:
1664
78
.
28.
Shin
S
,
Palis
BE
,
Phillips
JL
,
Stewart
AK
,
Perry
RR
. 
Cutaneous melanoma in Asian Americans
.
J Surg Oncol
2009
;
99
:
114
8
.
29.
Green
A
,
Whiteman
D
,
Frost
C
,
Battistutta
D
. 
Sun exposure, skin cancers and related skin conditions
.
J Epidemiol
1999
;
9
:
S7
13
.
30.
Naldi
L
,
Altieri
A
,
Imberti
GL
,
Giordano
L
,
Gallus
S
,
La Vecchia
C
. 
Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy
.
Ann Epidemiol
2005
;
15
:
545
50
.
31.
Veierod
MB
,
Weiderpass
E
,
Thorn
M
,
Hansson
J
,
Lund
E
,
Armstrong
B
, et al
A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women
.
J Natl Cancer Inst
2003
;
95
:
1530
8
.
32.
Gandini
S
,
Sera
F
,
Cattaruzza
MS
,
Pasquini
P
,
Zanetti
R
,
Masini
C
, et al
Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors
.
Eur J Cancer
2005
;
41
:
2040
59
.
33.
Sheehan
JM
,
Cragg
N
,
Chadwick
CA
,
Potten
CS
,
Young
AR
. 
Repeated ultraviolet exposure affords the same protection against DNA photodamage and erythema in human skin types II and IV but is associated with faster DNA repair in skin type IV
.
J Invest Dermatol
2002
;
118
:
825
9
.
34.
Del Bino
S
,
Sok
J
,
Bessac
E
,
Bernerd
F
. 
Relationship between skin response to ultraviolet exposure and skin color type
.
Pigment Cell Res
2006
;
19
:
606
14
.
35.
Green
A
. 
A theory of site distribution of melanomas: Queensland, Australia
.
Cancer Causes Control
1992
;
3
:
513
6
.
36.
Whiteman
D
,
Watt
P
,
Purdie
D
,
Hughes
M
,
Hayward
N
,
Green
A
. 
Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma
.
J Natl Cancer Inst
2003
;
95
:
806
12
.
37.
Rivers
JK
. 
Is there more than one road to melanoma?
Lancet
2004
;
363
:
728
30
.
38.
Elwood
JM
,
Gallagher
RP
. 
Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure
.
Int J Cancer
1998
;
78
:
276
80
.
39.
Whiteman
D
,
Stickley
M
,
Watt
P
,
Hughes
M
,
Davis
M
,
Green
A
. 
Anatomic site, sun exposure, and risk of cutaneous melanoma
.
J Clin Oncol
2006
;
24
:
3172
7
.
40.
Holman
CD
,
Armstrong
BK
,
Heenan
PJ
. 
Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits
.
J Natl Cancer Inst
1986
;
76
:
403
14
.
41.
Nelemans
PJ
,
Groenendal
H
,
Kiemeney
LA
,
Rampen
FH
,
Ruiter
DJ
,
Verbeek
AL
. 
Effect of intermittent exposure to sunlight on melanoma risk among indoor workers and sun-sensitive individuals
.
Environ Health Perspect
1993
;
101
:
252
5
.
42.
Armstrong
B
. 
Epidemiology of malignant melanoma: intermittent or total accumulated exposure to the sun?
J Dermatol Surg Oncol
1988
;
14
:
835
49
.
43.
Dennis
LK
,
Vanbeek
MJ
,
Beane
Freeman LE
,
Smith
BJ
,
Dawson
DV
,
Coughlin
JA
. 
Sunburns and risk of cutaneous melanoma: does age matter? A comprehensive meta-analysis
.
Ann Epidemiol
2008
;
18
:
614
27
.
44.
Elwood
JM
,
Gallagher
RP
,
Hill
GB
,
Pearson
JC
. 
Cutaneous melanoma in relation to intermittent and constant sun exposure–the Western Canada Melanoma Study
.
Int J Cancer
1985
;
35
:
427
33
.
45.
Elwood
J
,
Jopson
J
. 
Melanoma and sun exposure: an overview of published studies
.
Int J Cancer
1997
;
73
:
198
203
.
46.
Whiteman
D
,
Parsons
P
,
Green
A
. 
p53 expression and risk factors for cutaneous melanoma: a case-control study
.
Int J Cancer
1998
;
77
:
843
8
.
47.
Gandini
S
,
Sera
F
,
Cattaruzza
MS
,
Pasquini
P
,
Picconi
O
,
Boyle
P
, et al
Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure
.
Eur J Cancer
2005
;
41
:
45
60
.
48.
Walter
S
,
King
W
,
Marrett
L
. 
Association of cutaneous malignant melanoma with intermittent exposure to ultraviolet radiation: results of a case-control study in Ontario, Canada
.
Int J Epidemiol
1999
;
28
:
418
27
.
49.
Pukkala
E
,
Aspholm
R
,
Auvinen
A
,
Eliasch
H
,
Gundestrup
M
,
Haldorsen
T
, et al
Incidence of cancer among Nordic airline pilots over five decades: occupational cohort study
.
BMJ
2002
;
325
:
567
71
.
50.
Wagner
JK
,
Parra
EJ
,
Norton
HL
,
Jovel
C
,
Shriver
MD
. 
Skin responses to ultraviolet radiation: effects of constitutive pigmentation, sex, and ancestry
.
Pigment Cell Res
2002
;
15
:
385
90
.
51.
Kanetsky
PA
,
Panossian
S
,
Elder
DE
,
Guerry
D
,
Ming
ME
,
Schuchter
L
, et al
Does MC1R genotype convey information about melanoma risk beyond risk phenotypes?
Cancer
2010
;
116
:
2416
28
.
52.
Dwyer
T
,
Stankovich
JM
,
Blizzard
L
,
FitzGerald
LM
,
Dickinson
JL
,
Reilly
A
, et al
Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype?
Am J Epidemiol
2004
;
159
:
826
33
.
53.
Palmer
JS
,
Duffy
DL
,
Box
NF
,
Aitken
JF
,
O'Gorman
LE
,
Green
AC
, et al
Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?
Am J Hum Genet
2000
;
66
:
176
86
.
54.
Zell
JA
,
Cinar
P
,
Mobasher
M
,
Ziogas
A
,
Meyskens
FL
 Jr
,
Anton-Culver
H
. 
Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment
.
J Clin Oncol
2008
;
26
:
66
75
.
55.
Liu
V
,
Mihm
MC
. 
Pathology of malignant melanoma
.
Surg Clin North Am
2003
;
83
:
31
60
.
56.
Clark
WH
 Jr
,
Elder
DE
,
Guerry
D
 IV
,
Epstein
MN
,
Greene
MH
,
Van Horn
M
. 
A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma
.
Hum Pathol
1984
;
15
:
1147
65
.
57.
Greene
VR
,
Johnson
MM
,
Grimm
EA
,
Ellerhorst
JA
. 
Frequencies of NRAS and BRAF mutations increase from the radial to the vertical growth phase in cutaneous melanoma
.
J Invest Dermatol
2009
;
129
:
1483
8
.
58.
Gandini
S
,
Sera
F
,
Cattaruzza
MS
,
Pasquini
P
,
Abeni
D
,
Boyle
P
, et al
Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi
.
Eur J Cancer
2005
;
41
:
28
44
.
59.
Pollitt
RA
,
Clarke
CA
,
Swetter
SM
,
Peng
DH
,
Zadnick
J
,
Cockburn
M
. 
The expanding melanoma burden in California hispanics
.
Cancer
2011
;
117
:
152
61
.

Supplementary data